Execs On The Move: An Eli Lilly President Departs; Finance Positions Filled At NuVasive And DBV Technologies
Executive Summary
The president of Eli Lilly USA departs for CEO post at FibroGen, a developer of medicines for anemia, fibrotic disease and cancer; a former Mallinckrodt exec is CFO of NuVasive, a maker of products for spine surgery; DBV Technologies, an investigator of treatments for food allergies, also adds a CFO; and more.